Intestinal tuberculosis is a relatively common clinical disease, and early statistics: 51.1% to 70.4% of the autopsied cases who died of tuberculosis were complicated by intestinal tuberculosis. It means that intestinal tuberculosis is mostly part of severe systemic tuberculosis, and many tuberculosis professionals do not have a deep enough understanding of this disease, with more misdiagnosis and problems in treatment, leading to incomplete anti-tuberculosis treatment of patients and even serious complications: intestinal obstruction, intestinal perforation, intestinal hemorrhage, abdominal abscesses, etc., leading to death of patients. Patients with intestinal tuberculosis mostly have fever, wasting, weakness, malnutrition, and digestive system symptoms such as abdominal distension, abdominal pain, diarrhea or constipation, but some patients have insignificant abdominal symptoms. Due to the poor general condition of early patients, poor absorption of oral anti-tuberculosis drugs and malnutrition, patients are not treated well. Therefore, early anti-tuberculosis treatment should use intravenous drugs as much as possible, and nutritional preparations such as albumin, amino acids and fatty milk should be used, and blood transfusion should be given if necessary. Only when the nutritional status of patients improves can patients’ treatment achieve good results. If abdominal pain worsens, nausea, vomiting and inability to eat occur during the treatment, intestinal obstruction and intestinal perforation should be highly suspected and should be treated promptly, otherwise it may lead to the patient’s death. The course of antituberculosis treatment for concurrent intestinal tuberculosis should be long, about 1.5 years-2 years, and it is best to switch to oral antituberculosis drugs only after abdominal symptoms improve. Even if TB is cured, some patients still suffer from intestinal obstruction due to inattention to diet.